Fig. 2From: Pneumonic-type lung adenocarcinoma with KRAS G12V mutation and sustained response to AfatinibCT scan of lung-mediastinal window after four-cycles of adjuvant chemotherapy (A), at disease progression (B), and achieving lesion aera shrinkage (C)Back to article page